The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study
Open accessAbstract
BACKGROUND.: It is believed widely that chemotherapy‐induced cognitive impairment occurs in a subgroup of patients with breast cancer. However, recent reports have provided no evidence that chemotherapy affects cognition. In this study, the authors questioned whether cognitive compromise in patients with breast cancer is attributable to chemotherapy. In addition, the effects of therapy‐induced menopause and of the erythropoiesis‐stimulating factor darbepoetin α on cognitive performance were assessed. METHODS.: A battery of neuropsychological tests was used to assess cognitive performance in 101 patients with breast cancer before neoadjuvant chemotherapy (T1) and toward the end of neoadjuvant chemotherapy (T2) with combined epirubicin, paclitaxel, and cyclophosphamide with concomitant darbepoetin α. Repeated‐measures multiple analyses of variance and a reliable‐change approach were used for statistical analyses. RESULTS.: At T1, the group means ranged below the test norms in 5 of 12 cognitive tests. At T2, multiple analyses of variance (MANOVA) indicated a significant overall improvement in the test results (P < .001). After correcting for practice effects, cognitive decline predominated in 27% of patients, whereas improvement predominated in 28% of patients. Cognitive performance was not related significantly to self‐reported cognitive problems, anxiety and depression, menopause, or darbepoetin α administration. CONCLUSIONS.: Even before chemotherapy, a subgroup of patients with breast cancer showed cognitive compromise that was unrelated to anxiety or depression. During chemotherapy, cognitive function remained stable in most patients, improved in a subgroup, and deteriorated in another subgroup. The deterioration may have been caused by side effects of chemotherapy, but it also may have been related to currently unidentified factors that cause prechemotherapy cognitive compromise. Therapy‐induced menopause and darbepoetin α did not appear to influence cognition. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
The Neuropsychological Assessment
Ogden, J. A. (2005) · Fractured Minds · doi:10.1093/oso/9780195171358.003.0002 · Cited by 4,364
Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 4,019
Trail Making Test A and B: normative data stratified by age and education
Tombaugh, T. (2004) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(03)00039-8 · Cited by 3,239
Neuropsychological assessment, 4th ed.
Lezak, M. D., Howieson, D. B., Loring, D. W., Hannay, H. J., & Fischer, J. S. (2004) · Cited by 1,934
Trail making test: normative values from 287 normal adult controls
Giovagnoli, A. R., Del Pesce, M., Mascheroni, S., Simoncelli, M., Laiacona, M., & Capitani, E. (1996) · The Italian Journal of Neurological Sciences · doi:10.1007/bf01997792 · Cited by 1,111
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Mehrfachwahl-Wortschatz-Intelligenztest
Lehrl, S. (2005) · Cited by 729
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2695 · Cited by 557
Jenkins, V, Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603029 · Cited by 407
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510905 · Cited by 396
Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q.-L., Hu, H., Chemerynsky, I., Clemons, M., Crump, M., Goss, P. E., Warr, D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.119 · Cited by 380
Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003) · Psycho-Oncology · doi:10.1002/pon.742 · Cited by 357
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Cognitive impairment associated with adjuvant therapy in breast cancer
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006) · Psycho-Oncology · doi:10.1002/pon.964 · Cited by 320
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.-A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2005.05.001 · Cited by 315
ANDERSON-HANLEY, C., SHERMAN, M. L., RIGGS, R., AGOCHA, V. B., & COMPAS, B. E. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703970019 · Cited by 302
Fan, H. G. M., Houédé-Tchen, N., Yi, Q.-L., Chemerynsky, I., Downie, F. P., Sabate, K., & Tannock, I. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6550 · Cited by 280
Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., & van Dam, F. S. A. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf241 · Cited by 262
Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005) · Cancer · doi:10.1002/cncr.21469 · Cited by 242
Stress Response Syndromes and Cancer: Conceptual and Assessment Issues
Gurevich, M., Devins, G. M., & Rodin, G. M. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.4.259 · Cited by 233
Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer
Ahles, T. A., & Saykin, A. (2001) · Cancer Investigation · doi:10.1081/cnv-100107743 · Cited by 213
Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005) · The Breast · doi:10.1016/j.breast.2004.10.004 · Cited by 208
What do cancer patients mean when they complain of concentration and memory problems?
Cull, A., Hay, C., Love, S., Mackie, M., Smets, E., & Stewart, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.608 · Cited by 200
Practitioner’s Guide to Evaluating Change with Neuropsychological Assessment Instruments
(2000) · Critical issues in neuropsychology · doi:10.1007/978-1-4615-4233-9 · Cited by 186
Pre‐treatment factors related to cognitive functioning in women newly diagnosed with breast cancer
Cimprich, B., So, H., Ronis, D. L., & Trask, C. (2005) · Psycho-Oncology · doi:10.1002/pon.821 · Cited by 172
Neurocognitive Functioning in Posttraumatic Stress Disorder
Horner, M. D., & Hamner, M. B. (2002) · Neuropsychology Review · doi:10.1023/a:1015439106231 · Cited by 161
Donovan, K. A., Small, B. J., Andrykowski, M. A., Schmitt, F. A., Münster, P. N., & Jacobsen, P. B. (2005) · Cancer · doi:10.1002/cncr.21482 · Cited by 133
O’Shaughnessy, J., Vukelja, S. J., Holmes, F. A., Savin, M. A., Jones, M., Royall, D. R., George, M. J., & Hoff, D. D. V. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.002 · Cited by 114
Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., Metzner, B., Thiel, E., Zander, A. R., Schulz‐Kindermann, F., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj108 · Cited by 111
Self-citationShilling, V. M., Jenkins, V. A., & Solis‐Trapala, I. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9055-1 · Cited by 99
Bruggemans, E. F., van de Vijver, F. J. R., & Huysmans, H. A. (1997) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639708403743 · Cited by 74
Test-retest reliability of computerized, everyday memory measures and traditional memory tests
Youngjohn, J. R., Larrabee, G. J., & Crook, T. H. (1992) · The Clinical Neuropsychologist · doi:10.1080/13854049208404129 · Cited by 48
Klaiberg, A. (2003) · Diagnostica · doi:10.1026//0012-1924.49.1.45 · Cited by 45
Practitioner’s Guide to Evaluating Change with Intellectual Assessment Instruments
(2000) · Critical issues in neuropsychology · doi:10.1007/978-1-4615-4279-7 · Cited by 40
Test-retest Reliability and Practice Effects of a Rapid Screen of Mild Traumatic Brain Injury
Monte, V. E. D., Geffen, G. M., & Kwapil, K. (2005) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490918589 · Cited by 23
Cited by
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Metadata
- Authors
- Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-04-18
- Volume
- 109
- Issue
- 9
- Pages
- 1905-1913
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2114835134
- Cited by
- 356
- References
- 42
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.